Skip to content
Clinical Trials – home

Laryngeal cancer stage II Diagnostics

Clinical trials for Laryngeal cancer stage II

Recruiting trials first

See all 1 trials →
Quick filters

1 clinical trial in this condition

Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie-Panstwowy Instytut Badawczy
See all 1 trials →filters applied: condition = Laryngeal cancer stage II

In short

Diagnosing laryngeal cancer stage II involves a series of careful examinations and tests to understand the extent of cancer growth and plan the most appropriate treatment. Early detection through proper diagnostic procedures can significantly influence treatment outcomes and help doctors determine whether the cancer remains confined to the larynx or has begun to affect nearby structures.

Key points

  • Persistent hoarseness lasting more than two weeks should never be ignored—it's one of the most important early warning signs of laryngeal cancer.
  • Stage II laryngeal cancer remains confined to the larynx, which generally means better treatment outcomes with a five-year survival rate around 70%.
  • A comprehensive diagnosis involves physical examination, laryngoscopy or endoscopy, biopsy, and imaging tests to determine the exact extent of the disease.
  • The definition of stage II varies depending on whether the cancer started above, at, or below the vocal cords, making laryngeal cancer staging uniquely complex.
  • Tobacco use and heavy alcohol consumption are the leading risk factors, and continuing these habits can worsen your prognosis even after diagnosis.
  • A biopsy examined under a microscope is the only definitive way to confirm cancer and determine its characteristics.
  • Men over 55 face the highest risk of developing laryngeal cancer, being five times more likely than women to receive this diagnosis.
  • Your cancer care will involve a multidisciplinary team including surgeons, oncologists, speech therapists, and dietitians who work together to plan your treatment.

Introduction: Who Should Seek Diagnostic Testing

If you notice persistent changes in your voice, especially hoarseness that lasts longer than two weeks, it's important to see a healthcare provider. Many people mistakenly think these symptoms are just signs of a cold or minor throat irritation, but when they don't improve, they could indicate something more serious requiring medical attention.

You should especially consider getting checked if you experience a sore throat or cough that refuses to go away, trouble or pain when swallowing, unexplained ear pain, or a lump in your neck or throat. These symptoms might seem common, but when they persist, they warrant a thorough examination.

Certain warning signs require immediate medical attention. If you develop trouble breathing, noisy and high-pitched breathing sounds, the sensation that something is stuck in your throat, or if you cough up blood, you should seek medical care right away. These symptoms could indicate that the cancer is causing significant obstruction or other serious complications.

People who use tobacco products or drink alcohol heavily face a much higher risk of developing laryngeal cancer. If you fall into these categories and notice any throat or voice changes, early diagnostic testing becomes even more important. Men over age 55 are particularly at risk, as are people with a history of head and neck cancers. Those exposed to certain workplace substances like wood dust, asbestos, nickel, or sulfuric acid mist should also be vigilant about unusual symptoms.

Diagnostic Methods for Identifying Laryngeal Cancer

When you first visit a healthcare provider with concerns about your throat or voice, they will begin with a detailed conversation about your symptoms and medical history. This includes asking about your lifestyle habits, such as tobacco and alcohol use, and any previous illnesses or treatments. Understanding your personal health story helps doctors assess your risk and decide which tests are most appropriate.

Physical Examination of the Throat and Neck

The initial physical exam involves a careful inspection of your throat and neck. Your doctor will feel the inside of your mouth with a gloved finger and use a small mirror with a light to examine your throat. This process, while it might feel uncomfortable, allows them to check the insides of your cheeks and lips, your gums, the roof and floor of your mouth, all surfaces of your tongue, and your throat. They will also gently press along your neck to feel for swollen lymph nodes, which are small glands that can become enlarged when fighting infection or when cancer has spread.

Laryngoscopy

A laryngoscopy is one of the key procedures used to get a closer look at your larynx, which is your voice box. During this examination, your doctor uses either a mirror or a specialized instrument called a laryngoscope to check for abnormal areas. A laryngoscope is a thin, tube-like device equipped with a light and a lens that allows the doctor to view the inside of your throat and voice box in detail. This tool may also have attachments that can remove small tissue samples for further testing.

There are different types of laryngoscopy procedures. Some can be performed in the doctor's office with local numbing medication, while others might require general anesthesia in an operating room setting. The choice depends on how much of the larynx needs to be examined and whether tissue samples need to be collected.

Endoscopy

An endoscopy is a broader examination that looks at various organs and tissues inside your body, including the throat, esophagus (the tube connecting your throat to your stomach), and trachea (your windpipe). An endoscope is a thin, lighted tube with a camera that is inserted through an opening in your body, such as your mouth. This allows doctors to examine areas that are difficult to see otherwise and to check for abnormal growths or changes in tissue.

Biopsy

A biopsy involves removing cells or tissues so they can be examined under a microscope by a specialist called a pathologist. This is the definitive way to confirm whether cancer is present. The tissue sample may be collected during a laryngoscopy or endoscopy procedure. The pathologist looks for signs of cancer cells and can determine the type and characteristics of the cancer, which helps guide treatment decisions.

Imaging Scans

Imaging tests create detailed pictures of the inside of your body and help doctors see the size and location of tumors. CT scans (computed tomography scans) and MRI scans (magnetic resonance imaging) are commonly used for laryngeal cancer. These scans can show whether the cancer has grown into nearby structures or spread to lymph nodes. They provide three-dimensional images that help doctors plan treatment and understand the full extent of the disease.

During a CT scan, you lie still on a table that moves through a machine that takes multiple X-ray images from different angles. An MRI uses powerful magnets and radio waves instead of X-rays to create detailed images of soft tissues. Both procedures are painless, though you may need to receive a contrast dye through an IV to make certain structures show up more clearly on the images.

Understanding Stage II Laryngeal Cancer

Stage II laryngeal cancer means the cancer is still only in the larynx but has grown more extensively than in stage I. The specific definition depends on which part of the larynx the cancer started in. The larynx has three main sections: the supraglottis (upper part above the vocal cords), the glottis (middle part where the vocal cords are located), and the subglottis (lower part below the vocal cords).

For cancer that begins above the vocal cords in the supraglottis, stage II means the tumor has grown deeper into tissues and spread to more than one area of the supraglottis, though the vocal cords still move normally. When cancer starts in the vocal cords themselves (the glottis), stage II indicates it has spread either upward into the supraglottis, downward into the subglottis, or both, and the vocal cords may not move normally anymore. For cancer starting below the vocal cords in the subglottis, stage II means the tumor has reached the vocal cords, which may or may not be able to move normally.

Importantly, in all cases of stage II laryngeal cancer, the cancer has not yet spread to nearby lymph nodes or to other parts of the body. It remains confined to the larynx area, which generally means treatment options can focus on the local disease rather than addressing cancer that has traveled elsewhere.

Staging Systems and Classification

Doctors use a system called TNM staging to describe the extent of laryngeal cancer. TNM stands for Tumor, Node, and Metastasis. The T describes the size of the main tumor and whether it has grown into nearby structures. The N indicates whether cancer has spread to lymph nodes in the neck. The M tells whether the cancer has metastasized, or spread, to distant organs like the lungs or liver.

Each letter is assigned a number or additional letter that provides more detail. For example, T2 indicates a tumor of a certain size, N0 means no lymph nodes are involved, and M0 means no distant spread has occurred. When doctors combine these values, they can assign an overall stage from 0 to IV (4). Stage II falls in the middle of this range, indicating cancer that has grown locally but remains treatable with focused interventions.

The staging process is quite detailed for laryngeal cancer because each part of the larynx is surrounded by slightly different structures and tissues. This means the exact criteria for each stage vary depending on where in the larynx the cancer originated. Your healthcare team will explain your specific staging in terms you can understand and discuss what it means for your treatment plan.

Additional Diagnostic Information

Grading

Beyond staging, doctors also determine the grade of your cancer. The grade describes how abnormal the cancer cells look under a microscope compared to normal cells. This gives doctors insight into how the cancer might behave. Laryngeal cancer is typically graded on a scale of 1 to 3. Grade 1 cancers, also called well-differentiated, look very similar to normal larynx cells and tend to grow more slowly. Grade 2 cancers, or moderately differentiated, look somewhat abnormal. Grade 3 cancers, called poorly differentiated, look very abnormal and different from normal cells, and they may grow and spread more quickly.

Understanding Test Results

After all diagnostic tests are complete, your healthcare team will meet to discuss the results and develop a treatment plan. This team typically includes surgeons who specialize in head and neck cancers, oncologists who manage cancer treatment with medications and radiation, speech and language therapists, dietitians, and specialist nurses. Each member brings expertise to help address different aspects of your care.

Your doctor will explain what the tests revealed about your cancer, including its exact location, size, stage, and grade. They will also discuss what these findings mean for your treatment options and prognosis. It's completely normal to feel overwhelmed by all this information. Consider bringing a family member or friend to appointments to help you remember what was discussed, and don't hesitate to ask questions or request that information be explained again.

Prognosis and Survival Rate

Prognosis

The outlook for stage II laryngeal cancer is generally favorable compared to more advanced stages. Several factors influence how well a patient might respond to treatment and their overall prognosis. These include the exact location of the cancer within the larynx, the grade of the cancer cells, your overall health and fitness level, and whether you continue to use tobacco or alcohol during and after treatment.

Stage II means the cancer remains localized to the larynx and has not spread to lymph nodes or distant organs. This localized nature generally allows for more effective treatment with fewer complications than would be expected with more advanced disease. Your healthcare team will provide personalized information about your specific situation based on all the diagnostic findings.

Survival Rate

Statistics from England show that around 70 out of 100 people with stage II laryngeal cancer survive for five years or more after diagnosis. This means approximately 70% of patients are still alive five years after their diagnosis. It's important to understand that survival statistics are based on large groups of people and can't predict exactly what will happen in any individual case. Your personal outcome depends on many factors unique to your situation.

Five-year survival rates don't mean you will only live for five years—many people live much longer. These statistics simply represent a common time point that researchers use to measure outcomes. Stage II laryngeal cancer is considered early-stage disease, and the survival rates reflect this more favorable positioning compared to stages III and IV. Remember that survival rates are estimates based on past data and don't account for newer treatments that may have become available since the data was collected.

Did you know?

  1. The larynx is divided into three distinct sections, and stage II cancer is defined differently for each section, making laryngeal cancer staging particularly complex compared to other cancers.
  2. Men are about five times more likely to develop laryngeal cancer than women, possibly because smoking and heavy alcohol use have historically been more common among men.
  3. About 1 in 4 people who have had head and neck cancer will develop it again, highlighting the importance of long-term monitoring and lifestyle changes after initial treatment.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).